ACH
EVH icon

ArrowMark Colorado Holdings’s Evolent Health EVH Stock Holding History

ArrowMark Colorado Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,882,450
Closed -$51.3M – 339
2017
Q3 		$51.3M Buy
2,882,450
+1,397,580
+94% +$28.8M 0.58% 59
2017
Q2 		$37.6M Buy
+1,484,870
New +$35.7M 0.47% 77
2015
Q3 		– Sell
-20,000
Closed -$390K – 285
2015
Q2 		$390K Buy
+20,000
New +$373K 0.01% 280

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

ArrowMark Colorado Holdings's EVH Position: Q4 2017 in Review

ArrowMark Colorado Holdings sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 2,882,450 shares — an estimated $51.3M sold.

ArrowMark Colorado Holdings first reported a position in EVH in Q2 2015 and held it in 3 quarters. The position peaked at $51.3M in Q3 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • ArrowMark Colorado Holdings reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 2,882,450 Evolent Health shares in Q4 2017, an estimated $51.3M.
  • ArrowMark Colorado Holdings first reported a position in Evolent Health in Q2 2015 and held it in 3 quarters.
  • ArrowMark Colorado Holdings's Evolent Health position peaked at $51.3M in Q3 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.